Offer - Urjas Oil for just ₹ 1 X
T Lor Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
13 - 18 years (Adolescent) |
|
Geriatric |
|
Is the use of T Lor Tablet safe for pregnant women?
T Lor may have some side effects during pregnancy. Pregnant women should discontinue the use of T Lor, and talk to their doctor, if they notice any discomfort.
Is the use of T Lor Tablet safe during breastfeeding?
T Lor may have very limited harmful effects for breastfeeding women.
What is the effect of T Lor Tablet on the Kidneys?
Using T Lor does not have any harmful effects on kidneys.
What is the effect of T Lor Tablet on the Liver?
T Lor can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of T Lor Tablet on the Heart?
Very few cases of side effects of T Lor on the heart have been reported.
T Lor Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take T Lor Tablet unless your doctor advises you to do so -
Is this T Lor Tablet habit forming or addictive?
Yes, you can get addicted to T Lor Tablet. It is essential that you take [medicine] only after doctor's recommendation.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the T Lor Tablet can make you feel drowsy.
Is it safe?
Yes, but consume T Lor Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, T Lor Tablet is useful in treating mental disorders.
Interaction between Food and T Lor Tablet
Eating certain foods may increase the time it takes T Lor Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and T Lor Tablet
Consumption of alcohol and T Lor Tablet together may have severe effects on your health.
Yes, T Lor is safe to use, if taken in prescribed quantity for the prescribed duration. However, there are few side effects which have been observed at a therapeutic dose level such as drowsiness, dizziness, hallucination, shortness of breath, unusual changes in behavior, and problems with coordination or balance.
Yes, T Lor may cause dry mouth because it decreases the saliva secretion in your mouth. It is a known side effect of this drug. If you experience excessive dry mouth after taking this drug then try to keep yourself hydrated with juices, shakes and ample water.
No, T Lor does not treat bipolar disorder. However, sometimes it is used to control an acute episode of agitation in bipolar disorder. You are advised to consult with your doctor for better treatment options for bipolar disorder.
Yes, T Lor might cause hair loss (alopecia). It is a rare side effect of this drug which is unharmful and reversible in nature. This problem goes away after discontinuation of the drug. However, if you notice excessive hair loss then consult it with your doctor.
Yes, T Lor has been reported to cause suicidal, self-inflicting and distorted thoughts. If you are experiencing disorientation and life-threatening thoughts after taking this drug, consult your doctor immediately without any further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ativan (lorazepam)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 424,466
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 791-792